Cost-effectiveness Analysis of CYP2D6*10 Pharmacogenetic Testing to Guide the Adjuvant Endocrine Therapy for Postmenopausal Women with Estrogen Receptor Positive Early Breast Cancer in China

Wei, XX; Sun, H; Zhuang, J; Weng, XH; Zheng, B; Lin, QW; Zhang, GF; Cai, JQ

Cai, JQ (corresponding author), Fujian Med Univ, Dept Pharm, Fujian Prov Hosp, Shengli Clin Med Coll, Fuzhou 350001, Fujian, Peoples R China.

CLINICAL DRUG INVESTIGATION, 2020; 40 (1): 25

Abstract

BackgroundA CYP2D6 gene polymorphism is related to the effect of tamoxifen treatment in patient with estrogen-receptor positive (ER) positive breast c......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索